[2023]Targeting biophysical microenvironment for improved treatment of chronic obstructive pulmonary disease

上一条：[2023]Guideline on treating community-acquired pneumonia with Chinese patent medicines

下一条：[2023]Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling

【关闭】